ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

104 hedge funds and large institutions have $694M invested in Aclaris Therapeutics in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 23 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
-6
Holders Change %
-5.45%
% of All Funds
2.6%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
18
Increased
56
Reduced
23
Closed
24
Calls
$3.8M
Puts
–
Net Calls
+$3.8M
Net Calls Change
+$525K

Top Buyers

1
EAM
1
Eagle Asset Management
Florida
$36.8M
2
Franklin Resources
2
Franklin Resources
California
$53M
3
Westfield Capital Management
3
Westfield Capital Management
Massachusetts
$33.9M
4
BlackRock
4
BlackRock
New York
$32.5M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$23.4M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$0
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$0
3
EC
3
EcoR1 Capital
California
$5.03M
4
RSCM
4
Rock Springs Capital Management
Maryland
$11.9M
5
Fidelity International
5
Fidelity International
Bermuda
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
126
Meeder Asset Management
Ohio
– -$2K -72 Closed
2 3 4 5
6